Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

por Cives, Mauro, Pelle’, Eleonora, Strosberg, Jonathan
Publicado no J Clin Med (2020)

What is the role of checkpoint inhibitors in neuroendocrine neoplasms?

por Al-Toubah, Taymeyah, Pelle, Eleonora, Strosberg, Jonathan
Publicado no Oncotarget (2020)

Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/Temozolomide

por Al‐Toubah, Taymeyah, Morse, Brian, Pelle, Eleonora, Strosberg, Jonathan
Publicado no Oncologist (2020)

pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo

por Cafforio, Paola, Viggiano, Luigi, Mannavola, Francesco, Pellè, Eleonora, Caporusso, Concetta, Maiorano, Eugenio, Felici, Claudia, Silvestris, Francesco
Publicado no Stem Cell Res Ther (2017)

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

por Palmirotta, Raffaele, Lovero, Domenica, Cafforio, Paola, Felici, Claudia, Mannavola, Francesco, Pellè, Eleonora, Quaresmini, Davide, Tucci, Marco, Silvestris, Franco
Publicado no Ther Adv Med Oncol (2018)

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors

por Cives, Mauro, Partelli, Stefano, Palmirotta, Raffaele, Lovero, Domenica, Mandriani, Barbara, Quaresmini, Davide, Pelle’, Eleonora, Andreasi, Valentina, Castelli, Paola, Strosberg, Jonathan, Zamboni, Giuseppe, Falconi, Massimo, Silvestris, Franco
Publicado no Sci Rep (2019)